Evidence map›Paper›PMID 37460966›Full record

ArticleBMC gastroenterology2023

Retrospective analysis of vertical Hepatitis C exposure and infection in children in Western New York.

Ndeye Licka Dieye, Mine Varol, Shauna C Zorich, Amy E Millen, Karl O A Yu, Oscar G Gómez-Duarte

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pediatric Hepatitis C Screening by Maternal Hepatitis C Infection Status During Pregnancy.Journal of the Pediatric Infectious Diseases Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ndeye Licka DieyeInternational Enteric Vaccine Research Program (IEVRP), Division of Pediatric Infectious Diseases, The State University of New York (SUNY) at Buffalo, Buffalo, NY, USA.
Mine VarolInternational Enteric Vaccine Research Program (IEVRP), Division of Pediatric Infectious Diseases, The State University of New York (SUNY) at Buffalo, Buffalo, NY, USA.
Shauna C ZorichDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, State University of New York (SUNY) at Buffalo, Buffalo, NY, USA.
Amy E MillenDepartment of Epidemiology and Environmental Health, School of Public Health and Health Professions, State University of New York (SUNY) at Buffalo, Buffalo, NY, USA.
Karl O A YuInternational Enteric Vaccine Research Program (IEVRP), Division of Pediatric Infectious Diseases, The State University of New York (SUNY) at Buffalo, Buffalo, NY, USA.
Oscar G Gómez-DuarteInternational Enteric Vaccine Research Program (IEVRP), Division of Pediatric Infectious Diseases, The State University of New York (SUNY) at Buffalo, Buffalo, NY, USA. oscargom@buffalo.edu.
University at Buffalo, State University of New York · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVertical transmission of hepatitis C virus (HCV) is the primary cause of hepatitis C in the pediatric population. Nonetheless, only a small proportion of HCV-exposed children are tested. This study aimed to measure the proportion of HCV-exposed children tested and infected in Western New York and to identify factors influencing the odds of testing and infection in this population.

methodsThis was a 11-year retrospective chart review study in which clinical, demographic, and behavioral data for HCV-exposed children and their mothers were collected. This period included year 2019 when a hepatitis C program began promoting early hepatitis C screening among infants born to mothers positive for hepatitis C. PCR-based detection of hepatitis C was used for children under 18 months of age and antibody testing for children above 18 months of age, followed by PCR if the antibody testing was positive. Logistic regression models were used to determine which characteristics associate with testing and infection status.

resultsFrom a total of 133 children evaluated in clinic for hepatitis C from 2011 to 2021, 96.2% (128/133) were seen from 2019 to 2021. Among the 133 HCV-exposed children in our sample, 72.1% (96/133) were tested for HCV, 62.4% (83/133) were tested by PCR, 9.0% (12/133) tested by antibody, and 5.2% (5/95) of those tested were infected. Only one child out of 12 was positive for hepatitis C antibody yet, subsequent PCR testing was negative in this child. Among all five hepatitis C infected children, four were diagnosed with neonatal abstinence syndrome, five had maternal history of illicit drug use, one had maternal history of HIV infection, and all of them were identified after the hepatitis C program open in 2019. The odds of a child being tested were lower for those accompanied by their biological mother at their clinic visit (odds ratio, 0.16; 95% CI, 0.06-0.45).

conclusionsScreening programs on hepatitis C vertical transmission improved detection of hepatitis C among exposed children. The proportion of children born to mothers with hepatitis C in Western New York that were positive for hepatitis C was 5.2%, suggesting that similar proportion of exposed infants born before 2019 were lost for follow up.

Indexed as

Hepatitis CHIV InfectionsPregnancy Complications, InfectiousChildFemaleHepacivirusHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalNew YorkPregnancyRetrospective StudiesRNA, ViralRNA, ViralExposureHepatitis CInfantInfectionScreeningVertical transmissionWestern New York

Identifiers

PMID37460966
PMCPMC10353113
OpenAlexW4384523099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.